Term Name:	P-{alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6-yl}-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-P-6-[CH2]5NHC(=O)[CH2]4C(=O)NHR group
Synonyms:	(1-{(2R,3S,4R,5R,6R)-5-acetamido-4-{[(2S,3R,4R,5S,6R)-3-acetamido-6-({[({(2R,3S,4R,5R,6R)-5-acetamido-4-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(1R)-1-carboxy-2-hydroxyethoxy]-3-hydroxyoxan-2-yl}methoxy)(hydroxy)pho, alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6P3-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6P[CH2]5NH2NHC(=O)[CH2]4C(=O)NHR
Definition:	An organic group derived from alpha-D-GlcpNAc-(1->3)-[P-6-[CH2]5NH2]-alpha-D-GlcpNAc-(1->2)-D-GroA (CHEBI:134201) in which the 5-aminopentyl linker is replaced by a 6-(pentylamino)hexanamido one. When linked to the diphtheria toxin mutant 197CRM, it shows potential as a Clostridium difficile vaccine candidate.
Ontology:	ChEBI [CHEBI:134203]  ( EBI )